Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126855721 | 12685572 | 1 | I | 20151218 | 20151221 | 20160825 | 20160825 | PER | US-FRI-1000081998 | FOREST | 23.00 | YR | F | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126855721 | 12685572 | 1 | PS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | Y | 21323 | 10 | MG | ||||||||
| 126855721 | 12685572 | 2 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126855721 | 12685572 | 1 | Anxiety |
| 126855721 | 12685572 | 2 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126855721 | 12685572 | Disturbance in attention | |
| 126855721 | 12685572 | Dizziness | |
| 126855721 | 12685572 | Feeling abnormal | |
| 126855721 | 12685572 | Hypoaesthesia | |
| 126855721 | 12685572 | Impaired work ability | |
| 126855721 | 12685572 | Pruritus | |
| 126855721 | 12685572 | Throat tightness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126855721 | 12685572 | 1 | 20151217 | 20151217 | 0 |